drugset / Trial / NCT06742957
Study Comparing Tapinarof Cream 1% To VTAMA ® (Tapinarof Cream 1%) In the Treatment of Plaque Psoriasis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To compare the safety and efficacy of the test (Tapinarof Cream 1%), placebo (vehicle cream) and reference VTAMA® (Tapinarof Cream 1%) treatments to demonstrate clinical equivalence in patients with plaque psoriasis.
Timeline
- Start
- 2024-12-17
- Primary completion
- 2025-10-07
- Completion
- 2025-11-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tapinarof | Other / unclassified | 1 % | Topical |